The Latest Buzz:

SCCM Annual Congress
February 4-8, 2012
Houston, TX
Booth #622

HIMSS 2012
February 20-24, 2012
Las Vegas, NV
Booth #2655

Sentri7 Achieves EMR Module Meaningful Use Certification!
Read the press release.

Sentri7 Coverage:
  • 27,564 Licensed Beds
  •  Patients

Tired of searching through patient charts for intervention opportunities?

Sentri7 clinical decision support can identify and alert you to possible intervention opportunities in real-time with little effort. Reduce your clinical pharmacists' time spent reading through lab paperwork and get them more time in action on the floors. Sentri7 can eliminate inefficiencies and help streamline your clinical workflow.

Sentri7 Dramatically Improves Pharmacy Performance

Sentri7 can accelerate the productivity of clinical pharmacy programs while enhancing medication safety. Sentri7 can help the busy pharmacist with:

  • Joint Commission National Patient Safety Goal 3E - anticoagulation management
  • IV-to-PO conversion
  • Renal adjustment of medication dosing
  • Identifying patients affected by drug shortages
  • Pharmacokinetic programs
  • Patient Safety Indicators - ADR and AE avoidance

List of possible reports from Sentri7:

The following are real-world examples of clinical lists related to pharmacy in use by our current Sentri7 customers:

  • Sensitive and resistant drug/bug combinations
  • Anticoagulation status for DVT patients
  • Alerts for Kayexelate or Naloxone STAT orders
  • Erythropoetin: received epo + Hgb >/= 12
  • Renal dosing: scr >1.5 + age > 65 years + on selected renally-eliminated drugs
  • Potassium: diuretic + no k+ supplement + k<3.5
  • Digoxin: digoxin + digoxin level
  • Metformin: metformin + scr >1.4 and patient is female
  • IV-to-PO: on IV medication listed on target IV-to-PO conversion list
  • CMS Indicator: troponin > 0.2 or ckMB positive and not on a B-blocker, ACE/ARB/ASA/statin
  • Warfarin: warfarin + INR > 4.0
  • Patient receiving Aspirin, Clopidogrel, or NSAID and platelets < 50,000 mm3
  • Patient receiving Amphotericin, Foscarnet, Fluconazole, or Itraconazole and Creatinine >1.5 mg/dl and rising
  • Order for Phytonadione not scheduled as PRN
  • Order for Meperidine not scheduled as PRN
  • Target renally-eliminated medications and creatinine clearance < 50ml/min
  • Patient receiving Amitriptyline and patient's age >65


Or call 1-800-654-8395 to discuss.

TESTIMONIALS

"I have Sentri7 set up with lists to help with identifying patients that need renally-adjusted dosing. There's also a list that helps identify patients that are on IV medications which could potentially be switched to oral medications. Before Sentri7, it took about 4 hours a day to trudge through the renal dosing and IV-to-PO information. Now it only takes about 90 minutes."
Simone Bellamy, Clinical Coordinator, Arkansas Heart Hospital, 105-bed hospital


"We saw a 90% increase in the number of weekly changes in recommended therapy by pharmacists related to lab evaluations. There was also a 43% increase in the number of weekly changes in therapy related to the inappropriate indications for medications. And there was a 98% increase in changes in therapy related to inappropriate use of high-risk medications."
Steven Pickette, BSPharm, BCPS System Manager of Pharmacy Clinical Services Providence Health & Services, non-profit 27-hospital system


"Sentri7 helps mine the data from our hospital's information system and organize this data so that we can easily identify those patients in need of our interventions. Sentri7 provides us with the data we need without having to manually pull it from several sources one patient at a time. This allows us to be more productive with less effort."
Philip Rioux, Director of Pharmacy, Central Maine Medical Center, 250-bed hospital